News

argenx Schedules Call for 2024 Financial Results Review

argenx Schedules Call for 2024 Financial Results Review

Upcoming Financial Results Announcement

February 20, 2025 – argenx (Euronext & NASDAQ: ARGX) has announced a significant upcoming event. The global immunology company, dedicated to enhancing the lives of those facing severe autoimmune diseases, will host a conference call and audio webcast to discuss its financial performance and business insights.

Conference Call Details

The event is scheduled for Thursday, February 27, 2025, at 2:30 PM CET (8:30 AM ET). In this session, argenx will present its full-year financial results for 2024 and provide an update on its fourth-quarter operations.

How to Access the Webcast

Interested parties can access the live audio of the call via the Investors section of the argenx website. Following the event, a recording will be available for one year, ensuring that those unable to attend live can still catch up on the significant information shared.

Dial-In Numbers for Participants

Here are the dial-in numbers for various countries:

Belgium: 32 800 50 201
France: 33 800 943355
Netherlands: 31 20 795 1090
United Kingdom: 44 800 358 0970
United States: 1 800 715 9871
Japan: 81 3 4578 9081
Switzerland: 41 43 210 11 32

For participation, use the access code 3810049 and join the call 15 minutes early to ensure smooth entry.

About argenx

As a leader in immunotherapy, argenx focuses on addressing critical needs in the autoimmune disease landscape. Collaborating with leading academic institutions through its Immunology Innovation Program (IIP), the company transforms innovative technologies into effective antibody-based therapies.

Innovative Therapeutics

Among its key advancements, argenx developed the first globally approved neonatal Fc receptor (FcRn) blocker, used in multiple countries including the U.S., Japan, and EU regions. Their lead product, efgartigimod, is under evaluation for various serious autoimmune conditions and is part of a broader strategy involving several early-stage antibody candidates.

Ongoing Research and Development

The commitment to research and innovation remains central to argenx’s mission. With a strong focus on developing new therapies, the company aims to improve patient outcomes through advanced science and clinical trials.

Connect with argenx

For more detailed updates, visit www.argenx.com and connect through their social media platforms, including LinkedIn and Instagram.

Frequently Asked Questions

What is the purpose of the upcoming conference call?

The conference call is intended to discuss argenx's financial results for 2024 and provide updates on its business operations.

When is the conference call scheduled?

The call will take place on February 27, 2025, at 2:30 PM CET (8:30 AM ET).

How can I listen to the conference call?

Individuals can access the call through the Investors section of the argenx website.

What are some of argenx's key products?

One of the highlighted products is efgartigimod, the first approved neonatal Fc receptor blocker, undergoing evaluation for various autoimmune diseases.

How can I get in touch with argenx for inquiries?

For media inquiries, you can contact Ben Petok at bpetok@argenx.com. For investor questions, reach out to Alexandra Roy (US) at aroy@argenx.com or Lynn Elton (EU) at lelton@argenx.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 175

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 280

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 42

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 136

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 28

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 168

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 12

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 203

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 113

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 184

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights on Valneva's Declaration of Shares and Voting Rights

Updated Category News Views 142

Understanding Valneva's Declaration of Shares and Voting Rights VALNEVA This article delves into the significant updates regarding Valneva's shares and voting rights, as disclosed on July 31, 2025. These declarations are crucial for shareholders and potential investors as they provide insights into the company's capital structure and governance. Key Details of the...

Continue Reading
Empowering Future Leaders: Boyle Heights' All-Girls Robotics Team

Updated Category News Views 156

Empowering Future Leaders in STEM In a remarkable showcase of talent and creativity, the all-girls team from Boyle Heights Solis S.T.E.M. Magnet High School is making a significant impact on the global stage by competing in the Horizon Hydrogen Grand Prix World Finals. This competition emphasizes the importance of STEM education and motivates young women to thrive in...

Continue Reading
Emergency Actions Following South Korea's Largest Airline Crash

Updated Category News Views 398

South Korea's Urgent Response to Air Disaster In a significant response to the aviation crisis, acting President Choi Sang-mok has mandated an immediate overhaul of South Korea's airline safety protocols. This decision came after the nation faced its deadliest air disaster, resulting in a tragic loss of 179 lives when a flight encountered catastrophic failure in landing....

Continue Reading
Golub Capital BDC, Inc. Announces Q1 FY 2025 Earnings Call Date

Updated Category News Views 205

Golub Capital BDC, Inc. Schedules Release of Financial Results Golub Capital BDC, Inc., a prominent business development company known by its stock ticker NASDAQ: GBDC, has made an important announcement regarding its financial reporting. The company has confirmed that it will be releasing its financial results for the first quarter of fiscal year 2025, which ended on...

Continue Reading
Understanding GigaCloud Tech's Investment Potential and P/E Ratio

Updated Category News Views 126

GigaCloud Tech's Stock Performance Overview In today's trading session, GigaCloud Tech Inc. (GCT) shares are seeing a price of $24.17 with a modest gain of 0.42%. Over the last month, this stock has shown a positive trend, jumping by 15.89%. However, it has faced some challenges over the past year, showing a decline of 17.38%. Investors are keen on understanding if this...

Continue Reading